China’s Five-Year Plan for Biotech Making it Increasingly Attractive for Global Pharma
The China pharmaceutical industry is taking a multi-pronged approach to becoming a dominant player in Asia. Maybe even the world.
The China pharmaceutical industry is taking a multi-pronged approach to becoming a dominant player in Asia. Maybe even the world.
Greater import dependence makes countries more vulnerable to price shocks.
Jeff Ferry, CPA’s chief economist, takes a historical look at the early days of American industrial might, how it all went wrong through hyperglobalization, and where we must go from here.